Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery	Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm	Recruiting	Phase 2	2025-01-08		NCT06762782

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Nantong University	71
Huai'an First People's Hospital	20
Jiangsu Taizhou People's Hospital	20
Northern Jiangsu People's Hospital	51
Suzhou Municipal Hospital	28
The Affiliated Hospital of Xuzhou Medical University	68
The First Affiliated Hospital with Nanjing Medical University	319
The First People's Hospital of Changzhou	35
The First People's Hospital of Lianyungang	21
Xuzhou Central Hospital	7
Zhongda Hospital	46

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Nanjing Medical University	Nanjing	China	43